Latest filing published 05 Aug 2024 for Destiny Pharma plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sir Nigel Rudd: trading record in brief
This profile gathers the share dealings of Sir Nigel Rudd in Destiny Pharma plc. Between 4 June 2018 and 2 August 2024, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €49k. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2024 alone, the filings show 1 purchase and no sales.
On 5 August 2024 came the latest disclosure, an open-market purchase in Destiny Pharma plc. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sir Nigel Rudd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0London Stock Exchange, AIM market (XLON)RNS:5295798Canonical exit: 31 Oct 2024 (T+90)
- 39,100 shares@ £1.1004100.0% of flowLondon Stock Exchange, AIMISIN GB00BDHSP575FCA-NSM:LSE20180605124730_13667714_20200330111424291_23743-0Canonical exit: 2 Sept 2018 (T+90)
2 of 2 declarations